Recursion Announces Multi-Year Collaboration with Mila for Tech-Enabled Drug Discovery prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
SALT LAKE CITY, March 1, 2021 /PRNewswire/
Recursion, a digital biology company industrializing drug discovery, today announced the appointment of R. Martin Chavez as Chairman of its Board of Directors. Dr. Chavez, who joined Recursion s Board of Directors in 2020, will serve as the company s first independent Chairman. In this role, Dr. Chavez will oversee the organization s goals with regard to investor relations and apply his career-long innovation expertise to support Recursion s mission: to decode biology and radically improve lives. It has been such a pleasure to welcome multiple fantastic independent Board members to Recursion over the past year. Marty brings with him both a deep understanding of biology and technology, said Recursion Co-Founder and CEO Chris Gibson, Ph.D. Further, he has unique experience in bringing new technology and approaches to other complicated industries like finance as well as wisdom from decades of experience at senior lev